| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.4 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |